Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D003408:Cresols / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004357:Drug Synergism; D010134:Fenclonine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology; D007274:Injections, Intraperitoneal; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis*; D010293:Pargyline / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D012701:Serotonin; D013997:Time Factors
D003408:Cresols; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D011422:Propionates; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D002262:Carboxy-Lyases; D010134:Fenclonine; D009638:Norepinephrine